Krystal Biotech, Inc. KRYS Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s equity method investments?
- Krystal Biotech, Inc. (KRYS) reported equity method investments of $193.49M in Q1 2026.
- How has Krystal Biotech, Inc.'s equity method investments changed year-over-year?
- Krystal Biotech, Inc.'s equity method investments increased by 30.3% year-over-year, from $148.47M to $193.49M.
- What does equity method investments mean?
- Investments in other companies where the firm has significant influence.
- How do you interpret equity method investments?
- An increase reflects strategic expansion or successful performance of affiliates, while a decrease may indicate divestment or losses in those entities.
- How does equity method investments compare across companies?
- Common in biotech for companies engaged in collaborative research or joint ventures with other firms.